slotkoers
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
3.955 KRW | -0,25% |
|
-.--% | -9,29% |
2023 | GeneBioTech Co, Ltd rapporteert resultaten voor het eerste kwartaal eindigend op 31 maart 2023 | CI |
Vakgebied
Aantal werknemers: 39
Verkoop per activiteit
KRW in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
Feed Additives and Functional Foods Product
55,6
%
| 44 674 | 54,0 % | 44 210 | 55,6 % | -1,04% |
Feed Additives and Functional Foods Merchandise
44,4
%
| 38 085 | 46,0 % | 35 267 | 44,4 % | -7,40% |
Verkoop per regio
KRW in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
South Korea
100,0
%
| 82 759 | 100,0 % | 79 477 | 100,0 % | -3,97% |
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Chan-Ho Lee
CEO | Chief Executive Officer | 60 | - |
Joo-Sun Park
BRD | Director/Board Member | 49 | - |
Won-Tak Cho
BRD | Director/Board Member | 55 | - |
Yong-Gu Kim
PRN | Corporate Officer/Principal | 57 | - |
Sang-Kyu Choi
AUD | Comptroller/Controller/Auditor | 57 | - |
Jeong-Seon Kang
PRN | Corporate Officer/Principal | 60 | - |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Chan-Ho Lee
CEO | Chief Executive Officer | 60 | - |
Jeong-Seon Kang
PRN | Corporate Officer/Principal | 60 | - |
Won-Tak Cho
BRD | Director/Board Member | 55 | - |
Yong-Gu Kim
PRN | Corporate Officer/Principal | 57 | - |
Joo-Sun Park
BRD | Director/Board Member | 49 | - |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 1 | 8 610 587 | 6 093 149 ( 70,76 %) | 0 | 70,76 % |
Bedrijfsgegevens
![Adres GeneBioTech Co. ,Ltd(A086060)](https://cdn.zonebourse.com/static/address/20701903.png)
Sector
Verkoop per activiteit
Vaira. 1 jan. | Kapi. | |
---|---|---|
-9,29% | 24,71 mln. | |
+55,32% | 815 mld. | |
+44,05% | 641 mld. | |
-6,75% | 352 mld. | |
+13,56% | 314 mld. | |
+10,68% | 303 mld. | |
+16,57% | 242 mld. | |
+2,04% | 224 mld. | |
+13,31% | 218 mld. | |
+8,48% | 168 mld. |
- Beurs
- Aandelen
- Koers A086060
- Onderneming GeneBioTech Co. ,Ltd